期刊文献+

新型布洛芬衍生物的合成及其抗炎活性 被引量:3

Synthesis and Anti-inflammatory Activities of Novel Ibuprofen Derivatives
下载PDF
导出
摘要 以布洛芬为原料,依次与草酰氯和氨基酸(2a^2d)反应制得中间体布洛芬衍生物(3a^3d);3与可缓慢释放H2S的5-对羟基苯基-1,2-二硫杂环戊烯-3-硫酮(4)经酯化反应,合成了4个新型的S-(+)-布洛芬衍生物(5a^5d)。α-溴乙酰氯与4经酯化反应制得5-(4-α-溴乙酰氧基)-苯基-1,2-二硫杂环戊烯-3-硫酮(6);6与1经偶联反应合成了一个新型的S-(+)-布洛芬衍生物(7),5和7的结构经1H NMR,IR和HR-MS表征。二甲苯致小鼠耳肿胀试验结果表明:5a,5c,5d和7均有较强的抗炎活性。 Four intermediates( 3a - 3d),ibruprofen derivatives,were prepared by reaction of ibuprofen with oxalyl chloride then amino acid( 2a - 2d),respectively. Four novel S-( +)-ibuprofen derivatives( 5a - 5d) were synthesized by the esterification reaction of 3 with H2 S controlled-release donor( 5-p-hydroxyphenyl-1,2-dithicydopentene-3-thione)( 4). An intermediate 5-4-( α-bromoacetoxy)-phenyl-1,2-dithio-cyclopentene-3-thione( 6) was prepared by esferificationtion reaction of bromoacetyl chloride with 4. A novel S-( +)-ibuprofen derivative( 7) was synthesized by the coupling reaction of 6 with 1. The structures of 5 and 7 were characterized by^1 H NMR,IR and HR-MS. The results of anti-inflammation by xylene-induced mice ear swelling showed that 5a,5c,5d and 7 exhibited better anti-inflammatory activities.
机构地区 苏州大学药学院
出处 《合成化学》 CAS CSCD 北大核心 2014年第6期781-784,共4页 Chinese Journal of Synthetic Chemistry
基金 江苏高校优势学科建设工程项目 苏州市科技计划项目(SYS201317)
关键词 S-(+)-布洛芬衍生物 硫化氢供体 合成 抗炎活性 S-(+)-ibuprofen derivative hydrogen sulfide donor synthesis anti-inflammatory
  • 相关文献

参考文献6

  • 1Ekundi Valentim E, Santos K T, Camargo E A, et al.Differing effects of exogenous and endogenous hydrogensulphide in carrageenan-induced knee joint synovitis inthe rat [ J ]. Br J Pharmacol,2010,159 ( 7 ) 1463 -1474.
  • 2Li L, Rossoni G, Sparatore A, et al. Anti-inflammato-ry and gastrointestinal effects of a novel diclofenac de-rivative [J]. Free Radical Biology Medicine,2007,42(5):706-719.
  • 3Lee I, Cryer B. Epidemiology and role of nonsteroidalantiinflammatory drugs in causing gastrointestinalbleeding [ J ]. Gastrointestinal Endoscopy Clinics ofNorth America,2011,21(4) :597 -612.
  • 4宋恒,黄彬,敖桂珍,刘金宜,莫凌萱.S-(+)-布洛芬衍生物的合成[J].化学试剂,2013,35(7):653-654. 被引量:3
  • 5楚小晶,张英,乔春华,敖桂珍,杨圣伟,董燕.罗丹宁衍生物的合成及抗肿瘤活性[J].中国药科大学学报,2013,44(2):113-116. 被引量:1
  • 6XuGL, DuYF,Cheng J G, et al. Inhibition of in-flammatory mediators contributes to the anti-inflamma-tory activity of KYKZL-1 via MAPK and NF-kB path-way [ J ]. Toxicology and Applied Pharmacology, 2013,272(1);221 -229.

二级参考文献11

  • 1杨广东,王睿.硫化氢与细胞的增殖和凋亡[J].生理学报,2007,59(2):133-140. 被引量:15
  • 2WEGGEN S, ERIKSEN J L, DAS P, et al. A subset of NSAID lower amyloidogenic a beta 42 independently of cyclooxygenase activity [ J :. Nature, 2001,414 ( 6 836 ) : 212-216.
  • 3JANTZEN P T, CONNOR K E, DICARLO G, et al. Micro- glial activation and beta-amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 trans- genie mice[ J]. J. Neurosci. ,2002,22(6) :2 246-2 254.
  • 4ERIKSEN J L, SAGI S A, SMITH T E, et al. NSAIDs and enantiomers of flurbiprofen target y-secretase and lower A:+2 in vivo[ J]. J. Clin. Invest,2003,112(3) :440-449.
  • 5WILKINSON B L, CRAMER P E, VARVEL N H, et al. Ibuprofen attenuates oxidative damage through NOX2 in- hibition in Alzheimer' s disease [ J ]. Neurobio. Aging, 2012,33(1) :197. e21-32.
  • 6SISKOU I C, REKKA E A, KOUROUNAKIS A P, et al. Design and study of some novel ibuprofen derivatives with potential nootropic and neuroproteetive properties [ J ]. Bioorg. Med. Chem. ,2007,15(2) :951-961.
  • 7PENNY M. Long-term use of ibuprofen lowers Alzheimer disease risk[ J]. Neurology,2008,70 : 1 612-1 617.
  • 8BREITNER J C, BAKER L D, MONTINE T J, et al. Ex- tended results of the Alzheimer's disease anti-inflammato- ry prevention trial [ J ]. Alzheimer' s Dementia, 2011,7 (4) :402-411.
  • 9PATRICK L M ,EDITH G M. NSAIDs and alzheimer dis- ease: epidemiological, animal model and clinical studies[ J ]. Neurobio. Aging,2007,28 ( 5 ) : 639-647.
  • 10OHTSUKI S. New aspects of the blood-brain barrier train- sporters:its physiological roles in the central nervous sys- tem[ J]. Biol. Pharm. Bull. ,2004,27( 1 ) : 1 489-1 496.

共引文献2

同被引文献25

  • 1敖桂珍,张奕华,季晖,邓钢.对甲磺酰基苯乙烯环酮类衍生物的合成及抗炎活性[J].药学学报,2004,39(10):803-807. 被引量:8
  • 2姚中强,于孟学,韩淑玲.非甾体抗炎药[J].北京医学,2005,27(5):295-300. 被引量:37
  • 3赵一玫,夏丹,艾彩萍,项光亚.布洛芬衍生物的合成及抗炎活性[J].中国药物化学杂志,2005,15(6):360-362. 被引量:10
  • 4王哲清.实用高效的酰胺键形成试剂[J].中国医药工业杂志,2006,37(12):855-858. 被引量:3
  • 5Goldstein J L, Cryer B. Gastrointestinal injury associ- ated with NSAID use:A case study and review of risk factors and preventative strategies [ J ]. Drug Healthcare and Patient Safety,2015,7 : 31 - 41.
  • 6Suthar S K, Sharma M. Recent developments in chim- eric NSAIDs as safer anti-inflammatory agents [ J ]. Me- dicinal Research Reviews,2015,35 : 341 - 407.
  • 7Kangwan N, Park J M, Hahm K B. Development of GI-safe NSAID: Progression from the bark of willow tree to modern pharmacology [ J 1. Current Opinion in Pharmacoloav.2014.19 : 17 - 23.
  • 8Xu G L, Liu F, Ao G Z, et al. Anti-inflammatory effects and gastrointestinal safety of NNU-hdpa:A no- vel dual COX/5-LOX inhibitor[ J]. Eur J Pharmacol, 2009,611 : 100 - 106,.
  • 9Parveen M, Ali A, Ahmed S, et al. Synthesis,bioas- say, crystal structure and ab initio studies of Erlenmeyer azlactones[J].Spectrochimica Acta Part a-Molecular and Biomolecular Spectroscopy,2013,104:538 - 545.
  • 10Christian AGN, Falgue V. Amide bond formation and peptide cou- pling [J]. Cheminform,2005,61 (46):10 827 - 10 852.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部